Navigation Links
LCA-Vision Reports Tangible Results from Business Strategy

Urges Stockholders to Vote Gold Card and Reject Dissidents' Director Slate

CINCINNATI, Feb. 19 /PRNewswire-FirstCall/ -- LCA-Vision Inc. (Nasdaq: LCAV) today announced that it is mailing to its stockholders a letter in which it urges support for Company management and its Board of Directors.

The full text of the letter follows:

To My Fellow Stockholders:

Your LCA-Vision executive Team is producing tangible results from the aggressive implementation of our detailed business plan.

During the fourth quarter of 2008 we increased our share of the domestic laser vision correction services market to 11.9% from 10.5% in the third quarter, according to Market Scope, LLC, a leading independent ophthalmic industry researcher. In January 2009, our procedure volume grew 48% compared with December 2008 and, although January typically is our highest volume month, this compares very favorably with the 14% increase from December 2007 to January 2008.

Your executive Team, with the full support of your Board of Directors, has taken decisive action to fix a broken business model inherited from former management that does not work in the current economic environment. In 2008 we reduced marketing spend by 21%, cut general and administrative expense by 11% and reduced capital expenditures by 48%, all compared with 2007. Expense-reduction initiatives in 2008 yielded labor cost reductions annualized at $14 million (35% decrease in headcount) and aggressive cash management initiatives generated $3 million in cash flow. Comparing 2009 (the first full year of benefit from cost reductions taken in 2008) with 2007 (the last full year prior to these reductions), we expect the number of procedures for a vision center to reach cash-flow breakeven to decline from 125 to 105 per month.

We are taking actions to improve our business further. Our test of a fresh new marketing concept over a three-week period late in 2008 resulted in a 34% increase in procedures in 13 test markets compared with control markets. We expect even better results when we rollout this program nationwide with the addition of new messaging in March. We also are developing a Lifetime Vision model, which aims to keep LCA-Vision patients for life versus the old "Catch and Release" model instituted by former management that did not allow for repeat sources of revenue.

The Joffe Group offers a sketchy plan with little detail and you should reject their efforts to gain control of your Company. First, do not sign the Joffe Group's WHITE consent card. Second, if you have previously signed a WHITE consent card, you may revoke that consent by signing, dating and mailing the enclosed GOLD Consent Revocation Card immediately. Third, if you have not yet signed a card, you can show support for your Board by signing, dating and mailing the enclosed GOLD Consent Revocation Card.

We have accomplished much while continuing our unwavering focus on positive patient experiences and exceptional clinical outcomes that are the hallmark of LCA-Vision and our LasikPlus(R) vision centers. It is extremely important that the Joffe Group NOT SUCCEED in its effort to gain control of your Company at this critical time. We believe the Joffe Group's plans will derail our recent progress and kill the momentum your Board and management Team have begun to achieve. We ask that you act today and we thank you for your support.


Steven C. Straus

Chief Executive Officer

LCA-Vision filed its Definitive Consent Revocation Statement ("Consent Revocation Statement") with the Securities and Exchange Commission on Monday, February 9, 2009, and copies of the Consent Revocation Statement with a GOLD Consent Revocation Card were mailed to stockholders beginning February 10, 2009. The Consent Revocation Statement can be obtained immediately from the SEC's website at the following link:

or from the Investor Relations section of the Company's website at and Copies of the Consent Revocation Statement and consent revocation card may also be obtained from Georgeson Inc.

Additional Information:

Georgeson Inc. has been retained by LCA-Vision as consent revocation solicitation agent. Stockholders with questions are encouraged to call them toll-free 1-800-457-0109. Copies of the Company's Consent Revocation Statement, and any other documents filed by LCA-Vision with the SEC in connection with the consent solicitation can be obtained free of charge from the SEC's website at, from the Company's website at and, or from Georgeson.

Forward-looking Statements

This news release contains forward-looking statements based on current expectations, forecasts and assumptions of LCA-Vision that are subject to risks and uncertainties. The forward-looking statements are based on information available to us as of the date hereof. Actual results could differ materially from those stated or implied in such forward-looking statements due to risks and uncertainties associated with our business, including, without limitation, those concerning economic, political and sociological conditions; the acceptance rate of new technology, and our ability to successfully implement new technology on a national basis; market acceptance of our services; the successful execution of marketing strategies to cost effectively drive patients to our vision centers; competition in the laser vision correction industry; an inability to attract new patients; the possibility of long-term side effects and adverse publicity regarding laser vision correction; operational and management instability; legal or regulatory action against us or others in the laser vision correction industry; our ability to profitably operate vision centers and retain qualified personnel during periods of lower procedure volumes; the relatively high fixed cost structure of our business; the continued availability of non-recourse third-party financing for our patients on terms similar to what we have paid historically; and the future value of revenues financed by us and our ability to collect on such financings which will depend on a number of factors, including the worsening consumer credit environment and our ability to manage credit risk related to consumer debt, bankruptcies and other credit trends. In addition, an ongoing FDA study about post-Lasik quality of life matters could impact negatively the acceptance of Lasik. Except to the extent required under the federal securities laws and the rules and regulations promulgated by the Securities and Exchange Commission, we assume no obligation to update the information included herein, whether as a result of new information, future events or circumstances, or otherwise. For a further discussion of the factors that may cause actual results to differ materially from current expectations, please review our filings with the Securities and Exchange Commission, including, but not limited to, our reports on Forms 10-K, 10-Q and 8-K.

About LCA-Vision Inc./LasikPlus(R)

LCA-Vision Inc., a leading provider of laser vision correction services under the LasikPlus(R) brand, operates 75 LasikPlus(R) fixed-site laser vision correction centers in 32 states and 57 markets in the United States and a joint venture in Canada. Additional company information is available at and

Earning Trust Every Moment.

Transforming Lives Every Day.

For Additional Information

    Company Contact:                  Investor Relations Contact:
    Barb Kise                         Jody Cain
    LCA-Vision Inc.                   Lippert/Heilshorn & Associates
    513-792-9292                      310-691-7100

SOURCE LCA-Vision Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. LCA-Vision Announces Appointment of Edgar F. Heizer to Board of Directors
2. LCA-Vision Announces Consent Solicitation Deadline; Urges Stockholders to Return Gold Consent Revocation Card
3. LCA-Vision Announces Fourth Quarter and Full Year 2008 Financial Results
4. LCA-Visions National Lasik Network Named as U.S. Provider for National Vision Administrators
5. The LCA-Vision Full Value Committee Commences Consent Solicitation to Elect New Board of Directors at LCA-Vision (Nasdaq: LCAV) and Sends Letter to Stockholders
6. LCA-Vision to Hold Corporate Update Conference Call and Q&A Session on February 6
7. LCA-Vision to Announce Fourth Quarter and Full Year 2008 Financial Results on Tuesday, February 10, 2009
8. The LCA-Vision Full Value Committee Files Preliminary Consent Solicitation Statement to Reconstitute the Board of Directors of LCA-Vision Inc.
9. LCA-Vision Urges Stockholders to Take No Action Regarding the Joffe Groups Threatened Consent Solicitation
10. LCA-Visions Former Executive Management Team Sends Open Letter to LCA-Vision Stockholders
11. LCA-Vision Board of Directors Responds to Recent Letters from Stockholder Group
Post Your Comments:
(Date:12/1/2015)... ... December 01, 2015 , ... The Multiple System Atrophy Coalition has announced the ... System Atrophy (MSA) research, timed today to coincide with Giving Tuesday 2015, a global ... their ability to work and be productive, to do simple daily activities like walking ...
(Date:12/1/2015)... , ... December 01, 2015 , ... ... in rural West Tennessee to receive Gigabit Internet through a partnership this year ... America’s largest cities, Henderson is an attractive destination for entrepreneurs who want to ...
(Date:12/1/2015)... ... December 01, 2015 , ... Integrated Rental Services (“Integrated ... Industries International, LLC (“JII”). , With support from JII, Integrated Rental is poised ... hospitals, surgery centers, clinics, research labs and medical facilities across the United States. ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... and hematology continuing medical education (CME), today announced that the first annual School ... New York. , “The prevention, detection and treatment of gastrointestinal cancers are undergoing ...
(Date:12/1/2015)... ... December 01, 2015 , ... Dr. Paul Vitenas, one of the ... been named by MedEsthetics magazine as the Best Single Physician Practice in the nation. ... many elite aesthetic physicians honored by the industry publication. , Dr. Vitenas said ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... VANCOUVER , Dec. 1, 2015  Following an ... (NASDAQ: OGXI ) announced today that its Phase ... interim futility analysis of the intent-to-treat (ITT) population. In ... identified by the DMC. Both the DMC and OncoGenex ... expected in the second half of 2016, depending on ...
(Date:12/1/2015)... , Dec. 1, 2015 WellStar Health ... Dallas, Texas -based Tenet Healthcare,s five metro ... of Trustees approved the strategic move following the conclusion ... its proven clinical care models and patient safety programs ... to healthcare to new communities. --> ...
(Date:12/1/2015)... , Dec. 1, 2015   Nottingham Spirk ... today announced the publication of a free ... Direct-to-Consumer Medical Market". The whitepaper gives medical product ... successfully penetrating this lucrative segment. Nottingham ... products to manage their own health, save money ...
Breaking Medicine Technology: